Author
S. N. Langel
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2025 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 19 mutual co-author links5 papers
Recent·Most cited
- ImmunologyMucosal ImmunologyPeer-reviewedDOI 10.1016/j.mucimm.2025.01.002
- MicrobiologyMicrobiology SpectrumPeer-reviewed
Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters
P. J. Kuehl, J. Dearing, A. Werts…·S. N. Langel
This paper designs and validates an exposure system for efficient SARS-CoV-2 airborne transmission in Syrian hamsters, showing similar virological outcomes between 1:1 and 1:4 infected-to-naive ratios.
DOI 10.1128/spectrum.04717-22 - ImmunologybioRxiv
Distinct upper airway epithelium interferon-stimulated and profibrotic gene expression between adult and infant rhesus macaques infected with SARS-CoV-2
S. N. Langel, C. Garrido, C. Phan…·M. Blasi
This study compares SARS-CoV-2 infection effects in adult and infant rhesus macaques, finding distinct interferon-stimulated and profibrotic gene expression patterns in upper airway epithelium.
DOI 10.4049/immunohorizons.2200075 - ImmunologybioRxiv
Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model
S. N. Langel, S. Johnson, C. I. Martinez…·S. N. Tucker
This study shows oral and intranasal Ad5 SARS-CoV-2 vaccines reduce disease severity and viral transmission in golden hamsters.
DOI 10.1126/scitranslmed.abn6868 - MicrobiologybioRxiv
Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 replication and dampens inflammation in airway cells.
R. Goswami, V. S. Russell, J. J. Tu…·S. R. Permar
This study shows that the Hsp90 inhibitor SNX-5422 reduces SARS-CoV-2 replication and inflammation in airway cells, suggesting its potential as an early therapeutic.
DOI 10.1016/j.isci.2021.103412